Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

2.

A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS Study.

Pourdjabbar A, Hibbert B, Chong AY, Le May MR, Labinaz M, Simard T, Ramirez FD, Lugomirski P, Maze R, Froeschl M, Glover C, Dick A, Marquis JF, Bernick J, Wells G, So DY; CAPITAL Investigators..

Thromb Haemost. 2016 Oct 20;117(1). [Epub ahead of print]

PMID:
27761582
3.

Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction: A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System.

Rashid MK, Guron N, Bernick J, Wells GA, Blondeau M, Chong AY, Dick A, Froeschl MP, Glover CA, Hibbert B, Labinaz M, Marquis JF, Osborne C, So DY, Le May MR.

JACC Cardiovasc Interv. 2016 Oct 10;9(19):2014-2020. doi: 10.1016/j.jcin.2016.07.004.

PMID:
27712737
4.

Impact of Center Experience on Patient Radiation Exposure During Transradial Coronary Angiography and Percutaneous Intervention: A Patient-Level, International, Collaborative, Multi-Center Analysis.

Simard T, Hibbert B, Natarajan MK, Mercuri M, Hetherington SL, Wright R, Delewi R, Piek JJ, Lehmann R, Ruzsa Z, Lange HW, Geijer H, Sandborg M, Kansal V, Bernick J, Di Santo P, Pourdjabbar A, Ramirez FD, Chow BJ, Chong AY, Labinaz M, Le May MR, O'Brien ER, Wells GA, So D.

J Am Heart Assoc. 2016 May 31;5(6). pii: e003333. doi: 10.1161/JAHA.116.003333.

5.

Four-year experience with the CoreValve transcatheter heart valve.

Kovac J, Schuler G, Gerckens U, Müller R, Serruys PW, Bonan R, Labinaz M, den Heijer P, Mullen M, Tymchak W, Grube E.

EuroIntervention. 2016 Oct 10;12(8):e1039-e1046. doi: 10.4244/EIJY15M10_10.

6.

Does stent strut design impact clinical outcomes: comparative safety and efficacy of Endeavor Resolute versus Resolute Integrity zotarolimus-eluting stents.

Di Santo P, Simard T, Ramirez FD, Pourdjabbar A, Harnett DT, Singh K, Moreland R, Chong AY, Dick A, Labinaz M, Froeschl M, Froeschl M, Le May MR, So DY, Hibbert B.

Clin Invest Med. 2015 Oct 7;38(5):E296-304.

PMID:
26854891
7.

Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications.

Fu A, Singh K, Abunassar J, Malhotra N, Le May M, Labinaz M, Glover C, Marquis JF, Froeschl M, Dick A, Hibbert B, Chong AY, So DY; CAPITAL Investigators..

Clin Cardiol. 2016 Jan;39(1):19-23. doi: 10.1002/clc.22486.

8.

Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.

Rodés-Cabau J, Horlick E, Ibrahim R, Cheema AN, Labinaz M, Nadeem N, Osten M, Côté M, Marsal JR, Rivest D, Marrero A, Houde C.

JAMA. 2015 Nov 24;314(20):2147-54. doi: 10.1001/jama.2015.13919.

PMID:
26551304
9.

Transcatheter Aortic Valve Implantation: Current and Evolving Indications.

Yousef A, Froeschl M, Hibbert B, Burwash IG, Labinaz M.

Can J Cardiol. 2016 Feb;32(2):266-9. doi: 10.1016/j.cjca.2015.04.033. Review.

PMID:
26481084
10.

Transfemoral vs Non-transfemoral Access for Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis.

Chandrasekhar J, Hibbert B, Ruel M, Lam BK, Labinaz M, Glover C.

Can J Cardiol. 2015 Dec;31(12):1427-38. doi: 10.1016/j.cjca.2015.04.023. Review.

PMID:
26319968
11.

Late Presentation of Left Main Coronary Artery Impingement Post-Transcatheter Aortic Valve Replacement.

Lugomirski P, McArdle B, Alak A, Dick A, Labinaz M.

JACC Cardiovasc Interv. 2015 Aug 24;8(10):e159-60. doi: 10.1016/j.jcin.2015.03.033. No abstract available.

12.

Percutaneous coronary intervention with RACER renal stents in very large diameter coronary arteries.

Harnett DT, Maze R, Pourdjabbar A, Ramirez FD, Simard T, Di Santo P, Gallagher S, Singh K, So D, Le May MR, Labinaz M, Hibbert B, Chong AY, Glover C; CAPITAL investigators..

Int J Cardiol. 2015 Dec 15;201:342-4. doi: 10.1016/j.ijcard.2015.03.007. No abstract available.

PMID:
26301676
13.

Safety and Efficacy of Staged Percutaneous Coronary Intervention During Index Admission for ST-Elevation Myocardial Infarction With Multivessel Coronary Disease (Insights from the University of Ottawa Heart Institute STEMI Registry).

Russo JJ, Wells GA, Chong AY, So DY, Glover CA, Froeschl MP, Hibbert B, Marquis JF, Dick A, Blondeau M, Bernick J, Labinaz M, Le May MR; CAPITAL Investigators..

Am J Cardiol. 2015 Oct 15;116(8):1157-62. doi: 10.1016/j.amjcard.2015.07.029.

PMID:
26282725
14.

A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic window.

Malhotra N, Abunassar J, Wells GA, McPherson R, Fu A, Hibbert B, Labinaz M, Le May M, Dick A, Glover C, Froeschl M, Marquis JF, Tran L, Bernick J, Chong AY, So DY; CArdiovascular Percutaneous Intervention TriAL (CAPITAL) investigators..

Int J Cardiol. 2015 Oct 15;197:318-25. doi: 10.1016/j.ijcard.2015.06.016.

PMID:
26151596
15.

Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis.

Yousef A, Simard T, Webb J, Rodés-Cabau J, Costopoulos C, Kochman J, Hernández-Garcia JM, Chiam PT, Welsh RC, Wijeysundera HC, García E, Ribeiro HB, Latib A, Huczek Z, Shanks M, Testa L, Farkouh ME, Dvir D, Velianou JL, Lam BK, Pourdjabbar A, Glover C, Hibbert B, Labinaz M.

Int J Cardiol. 2015;189:282-8. doi: 10.1016/j.ijcard.2015.04.066.

PMID:
25910593
16.

A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study.

So DY, Wells GA, McPherson R, Labinaz M, Le May MR, Glover C, Dick AJ, Froeschl M, Marquis JF, Gollob MH, Tran L, Bernick J, Hibbert B, Roberts JD.

Pharmacogenomics J. 2016 Feb;16(1):71-8. doi: 10.1038/tpj.2015.17.

PMID:
25850030
17.

Pulmonary hypertension due to fibrosing mediastinitis treated successfully with stenting of pulmonary vein stenoses.

Doucet KM, Labinaz M, Chandy G, Mielniczuk L, Stewart D, Contreras-Dominguez V, Pugliese C, Dennie C, Burwash IG, Davies RA.

Can J Cardiol. 2015 Apr;31(4):548.e5-7. doi: 10.1016/j.cjca.2014.12.025.

PMID:
25840104
18.

Subannular prosthetic valve embolization complicating transapical transcatheter aortic valve implantation: management without sternotomy.

Chandrasekhar J, Glover C, Al-atassi T, Ruel M, McPhedran R, Dickie S, Burwash I, Labinaz M, Lam BK.

Can J Cardiol. 2015 Feb;31(2):227.e7-9. doi: 10.1016/j.cjca.2014.10.038.

PMID:
25661562
19.

Efficacy of a device to narrow the coronary sinus in refractory angina.

Verheye S, Jolicœur EM, Behan MW, Pettersson T, Sainsbury P, Hill J, Vrolix M, Agostoni P, Engstrom T, Labinaz M, de Silva R, Schwartz M, Meyten N, Uren NG, Doucet S, Tanguay JF, Lindsay S, Henry TD, White CJ, Edelman ER, Banai S.

N Engl J Med. 2015 Feb 5;372(6):519-27. doi: 10.1056/NEJMoa1402556.

20.

Prophylactic warfarin therapy after primary percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.

Le May MR, Acharya S, Wells GA, Burwash I, Chong AY, So DY, Glover CA, Froeschl MP, Hibbert B, Marquis JF, Dick A, Blondeau M, Bernick J, Labinaz M.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):155-62. doi: 10.1016/j.jcin.2014.07.018.

Items per page

Supplemental Content

Loading ...
Support Center